Table 2.
Age of COVID-19 case | Symptoms | Clinical History | Clinical examination | Treatment | Study Findings and Conclusion | Reference |
---|---|---|---|---|---|---|
60-year-old male | severe breathlessness, pyrexia, tachypnea, and generalized malaise | diabetic (>10 years) pulse rate was 80/minute, blood pressure was 150/90 mmHg, Patient was afebrile on admission, respiratory rate was 26/minute, with a specific oxygen saturation of 86% on oxygen supplementation (10 L/min) bilateral crepts at the lung non-healing ulcer with the diabetic peripheral vascular disease was observed on right foot |
|
oral anti hypoglycemic tablets intravenous meropenem, oral oseltamivir with intravenous methylprednisolone and dexamethasone subcutaneous enoxaparin (40mg/0.4 ml) twice daily |
|
Mehta and Pandey, (2020) |
33-year-old Somali female | hypertension and asthma with altered mental status | patient began with symptoms of vomiting, cough, and shortness of breath 2 days prior to presentation. Signs of mild tachycardia, hypertension, and tachypnea. Afebrile and normal oxygen saturation. Left eye ptosis with 1 cm proptosis |
|
Vancomycin and piperacillin-tazobactam, Amphotericin B |
|
Werthman-Ehrenreich (2021) |
60-year-old man | diabetes, asthma, hypertension, hyperlipidemia and recent travel with dyspnea and hypoxia | Reported COVID-19 negative, and was discharged and later noticed with elevated level of glucose with oxygen demand. Was tested COVID-19 with ARDS |
|
Intravenous vancomycin and cefepime, antifungal coverage with liposomal amphotericin B, and strict glucose management. Dexamethasone 6 mg daily and a single dose of convalescent plasma as a treatment for COVID-19 |
|
Mekonnen et al, (2021) |
9 patients | COVID-19 infection | Post-mortem examination conducted. |
|
– |
|
Hanley et al. (2020) |
86-year-old male | arterial hypertension with acute diarrhea, cough, dyspnea, and fever | Throat swab confirmed COVID-19 |
|
ceftriaxone, azithromycin, oseltamivir, and hydrocortisone was provided. |
|
do Monte Junior et al. (2020) |
44-year-old women | Diabetes mellitus observed. Fever, malaise, myalgia, dry cough and partial dyspnoea was noticed. | Positive for influenze and negative for COVID-19 |
|
amphotericin B and posaconazole was administered. |
|
Ahmadikia et al. (2021) |
41-year-old man | Diabetes mellitus with loss of taste and cough. | Deep pain in the nose which radiated to throat. Oral cavity noted with black eschar |
|
Cefepime and IV abelcet, which is amphotericin B complexed with two phospholipids |
|
Alekseyev et al. (2021) |
31 patients | Diabetes, COVID-19 | Vision diminution and ophthalmoplegia |
|
amphotericin B |
|
Ravani et al. (2021) |
6 patients | COVID-19 | ptosis and ophthalmoplegia, edema, ptosis and proptosis, conjunctival congestion, and severe chemosis |
|
Corticosteroids, posaconazole was initiated |
|
Sen et al. (2021) |
55-year-old man | diabetes mellitus, hypertension, and ischemic cardiomyopathy presented with fever, dry cough, and progressive breathlessness | Respiratory rate was 26 breaths/minute, blood pressure 110/80 mmHg, and heart rate of 90 beats/minute. The oxygen saturation was 84% |
|
examethasone and remdesivir |
|
Garg et al. (2021) |
66-year-old male | COVID-19 positive | Deterioration of oxygen. |
|
hydroxychloroquine and lopinavir-ritonavir |
|
Pasero et al. (2020) |
38-year-old male | COVID-19 positive. | high grade fever, body ache, cough and shortness of breath |
|
Methylprednisolone, Dexamethasone. Intravenous Fluconazole and Amphotericin B |
|
Maini et al. (2021) |
32 year old women | Diabetes with ptosis and left facial pain |
|
– |
|
Saldanha et al. (2021) | |
Middle aged women | Diabetes mellitus with ptosis | Sinuses on the left side |
|
Amphotericin B and aspirin. Antifungal treatment |
|
Revannavar et al. (2021) |
40-year old woman and a 54-year old man | COVID-19 | – |
|
corticosteroid therapy and amphotericin B |
|
Veisi et al. (2021) |
79-year old male | diabetes mellitus and hypertension | fevers, rigors, dry cough, and worsening shortness of breath |
|
Ceftriaxone, azithromycin, remdesivir, dexamethasone, voriconazole |
|
Johnson et al. (2021) |
68-year old male | Hyperglycemia and acute renal failure | non-productive cough with non-bloody diarrhea, fever |
|
Prednisone, mycophenolate mofetil, tacrolimus, atovaquone, nystatin, valganciclovir, hydroxychloroquine |
|
Khatri et al. (2021) |
2 cases (Abstract) | diabetes mellitus and ketoacidosis | – | – | corticosteroids |
|
Dallalzadeh et al. (2021) |
24-year-old female | Obesity | COVID-19 with respiratory failure and oxygen saturation |
|
– |
|
Waizel-Haiat et al. (2021) |
49-year-old male | – | fever, cough, and shortness of breath |
|
ceftriaxone and azithromycin, enoxaparin, remdesivir |
|
Placik et al. (2020) |
53-year old male | acute myeloid leukemia, myelodysplastic syndrome, obesity and depression | sore throat, parageusia, dysosmia and fever |
|
Corticosteroids and antibacterial therapy |
|
Zurl et al. (2021) |
66-year-old male | Diabetes mellitus | – |
|
– |
|
Rao et al. (2021) |
56-year-old man | Renal disease | fatigue and shortness of breath |
|
methylprednisolone and tocilizumab |
|
Kanwar et al. (2021) |
31 patients | Different diseases | COVID-19 symptoms |
|
– |
|
Rashid et al. (2021) |
18 patients | 16 patients were diabetic | facial cellulitis, maxillary sinusitis, headache, necrosis of palatal bone/mucosa or acute loss of vision |
|
voriconazole, posaconazole |
|
Moorthy et al. (2021) |
55-year-old man | follicular lymphoma | Inflammatory response |
|
amphotericin B |
|
Bellanger et al. (2021) |
23 patients | Diabetes mellitus, renal failure and hypertension | COVID-19 positive cases |
|
Steroids |
|
Sharma et al. (2021) |
ARDS: acute respiratory distress syndrome; EGD: Esophagogastroduodenoscopy; GMS: Grocott's methenamine staining; H&E: haematoxylin and eosin; LCB: Lactophenol cotton blue; BAL: bronchoalveolar lavage; PAS: periodic acid–Schiff; KOH: potassium hydroxide; MALDI-TOF: Matrix-assisted laser desorption ionization time-of-flight; MRI: magnetic resonance imaging, CT: computed tomography; COVID-19: coronavirus disease 2019; RT-PCR: reverse transcription polymerase chain reaction.